Search
for
Sort by
Research 30 of 1000+
- Bone density is normal in male rats treated with finasteride.
- Premature Graying, Balding, and Low Bone Mineral Density in Older Women and Men
- Bone density is normal in male rats treated with finasteride
- Calcium and Vitamin D Supplementation with and Without Collagen on Bone Density and Skin Elasticity in Menopausal Women—A Randomized Controlled Study
- Effects of Intramuscular Testosterone Undecanoate on Body Composition and Bone Mineral Density in Female-to-Male Transsexuals
- Physical Changes, Laboratory Parameters, and Bone Mineral Density During Testosterone Treatment in Adolescents with Gender Dysphoria
- The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial.
- Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess
- A Single Injection of the Anabolic Bone Agent, Parathyroid Hormone–Collagen Binding Domain (PTH–CBD), Results in Sustained Increases in Bone Mineral Density for up to 12 Months in Normal Female Mice
- Changes in bone mineral density in women with early-onset androgenetik alopecia and their correlations with hair-loss stages: a cross-sectional study
- Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone
- Bone mineral density in hyperandrogenic amenorrhoea
- Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroids.
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Hair Calcium Concentration is Associated with Calcium Intake and Bone Mineral Density
- The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
- The Long-Term Effect Of Specific Type II 5α-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled Trial
- The solar window hypothesis: androgenetic alopecia as an evolutionary adaptation to maintain bone mineral density in vitamin D receptor low-efficiency variants
- The Long-Term Effect Of Specific Type II 5??-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled Trial
- 190 A cross-sectional study evaluating skin, hair, nail and bone disease in patients with focal dermal hypoplasia
- Bone Health - Running. Can You Outrun Your Past?
- Bone Metabolism in Patients with Hidradenitis Suppurativa: A Case-control Study
- Identification of key genes and signaling pathways related to Hetian sheep wool density by RNA-seq technology
- Acute Hair Loss 3 Years after Bone Marrow Transplant
- Feather arrays are patterned by interacting signalling and cell density waves
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations
- Endocrine intervention for transsexuals
- Potential adverse effects of long-term testosterone therapy
- Anabolic effects of testosterone are preserved during inhibition of 5α-reductase